Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 3
2006 4
2007 5
2008 8
2009 4
2011 1
2013 2
2014 4
2015 2
2016 3
2017 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Doxycycline in early CJD: a double-blinded randomised phase II and observational study.
Varges D, Manthey H, Heinemann U, Ponto C, Schmitz M, Schulz-Schaeffer WJ, Krasnianski A, Breithaupt M, Fincke F, Kramer K, Friede T, Zerr I. Varges D, et al. Among authors: krasnianski a. J Neurol Neurosurg Psychiatry. 2017 Feb;88(2):119-125. doi: 10.1136/jnnp-2016-313541. Epub 2016 Nov 2. J Neurol Neurosurg Psychiatry. 2017. PMID: 27807198 Free PMC article. Clinical Trial.
Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance.
Heinemann U, Krasnianski A, Meissner B, Varges D, Kallenberg K, Schulz-Schaeffer WJ, Steinhoff BJ, Grasbon-Frodl EM, Kretzschmar HA, Zerr I. Heinemann U, et al. Among authors: krasnianski a. Brain. 2007 May;130(Pt 5):1350-9. doi: 10.1093/brain/awm063. Brain. 2007. PMID: 17472986
Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial.
Haïk S, Marcon G, Mallet A, Tettamanti M, Welaratne A, Giaccone G, Azimi S, Pietrini V, Fabreguettes JR, Imperiale D, Cesaro P, Buffa C, Aucan C, Lucca U, Peckeu L, Suardi S, Tranchant C, Zerr I, Houillier C, Redaelli V, Vespignani H, Campanella A, Sellal F, Krasnianski A, Seilhean D, Heinemann U, Sedel F, Canovi M, Gobbi M, Di Fede G, Laplanche JL, Pocchiari M, Salmona M, Forloni G, Brandel JP, Tagliavini F. Haïk S, et al. Among authors: krasnianski a. Lancet Neurol. 2014 Feb;13(2):150-8. doi: 10.1016/S1474-4422(13)70307-7. Epub 2014 Jan 8. Lancet Neurol. 2014. PMID: 24411709 Clinical Trial.
A proposal of new diagnostic pathway for fatal familial insomnia.
Krasnianski A, Sanchez Juan P, Ponto C, Bartl M, Heinemann U, Varges D, Schulz-Schaeffer WJ, Kretzschmar HA, Zerr I. Krasnianski A, et al. J Neurol Neurosurg Psychiatry. 2014 Jun;85(6):654-9. doi: 10.1136/jnnp-2013-305978. Epub 2013 Nov 18. J Neurol Neurosurg Psychiatry. 2014. PMID: 24249784 Free PMC article.
Brain biopsy in patients with suspected Creutzfeldt-Jakob disease.
Heinemann U, Krasnianski A, Meissner B, Kallenberg K, Kretzschmar HA, Schulz-Schaeffer W, Zerr I. Heinemann U, et al. Among authors: krasnianski a. J Neurosurg. 2008 Oct;109(4):735-41. doi: 10.3171/JNS/2008/109/10/0735. J Neurosurg. 2008. PMID: 18826363
Clinical findings and diagnosis in genetic prion diseases in Germany.
Krasnianski A, Heinemann U, Ponto C, Kortt J, Kallenberg K, Varges D, Schulz-Schaeffer WJ, Kretzschmar HA, Zerr I. Krasnianski A, et al. Eur J Epidemiol. 2016 Feb;31(2):187-96. doi: 10.1007/s10654-015-0049-y. Epub 2015 Jun 16. Eur J Epidemiol. 2016. PMID: 26076917
Fatal familial insomnia: Clinical features and early identification.
Krasnianski A, Bartl M, Sanchez Juan PJ, Heinemann U, Meissner B, Varges D, Schulze-Sturm U, Kretzschmar HA, Schulz-Schaeffer WJ, Zerr I. Krasnianski A, et al. Ann Neurol. 2008 May;63(5):658-61. doi: 10.1002/ana.21358. Ann Neurol. 2008. PMID: 18360821
34 results